Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration with Bayer

News   Jun 26, 2013

 
Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration with Bayer
 
 
 

RELATED ARTICLES

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

Oligonucleotide Drug Producers Report on Drug Impurities

News

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.

READ MORE

Searching for the CRISPR Swiss-army Knife

News

High-resolution structural comparison of Cpf1 and Cas9 could help researchers achieve more accurate gene editing with CRISPR.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE